FEBS Letters · 1999 · 63 citations · 16 references
MedicineCancer BiologyOncologyMetastasisMolecular OncologyTumor ProgressionAngiogenesisAngiogenesis In CancerCancer Cell SignalingCartilage BiologyMalignant NeoplasmsCartilage Angiogenesis InhibitionTumor Growth Rate
Chondromodulin-I (ChM-I) was previously identified as an angiogenesis inhibitor in cartilage. Here, we demonstrated that the level of ChM-I transcripts was substantially reduced to 100 or even less in the lower-grade chondrosarcomas, in articular cartilage or other benign cartilage tumors. We implanted human chondrosarcoma OUMS-27 cells into nude mice that reproducibly produced tumors with cartilaginous matrix. Tumor-induced angiogenesis was evident when the tumors were excised 30 days after implantation. However, the local administration of recombinant human ChM-I almost completely blocked vascular invasion and tumor growth in vivo. Moreover, ChM-I also inhibited the growth of HT-29 colon adenocarcinoma in vivo, implying its therapeutic potential for solid tumors.
16
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
Michael S. O’Reilly, Thomas Boehm, Yuen Shing et al. · Cell · 1997 · 4.5K citations · Full text
Medicine, Oncology, Pharmacology +11
Adriano Miziara Gonzalez, Marino Buscaglia, Michael Ong et al. · The Journal of Cell Biology · 1990 · 529 citations · Full text